CompletedNCT03102918
Cannabidiol for Adults With Cannabis Use Disorder: A Placebo-Controlled Study
About this title
Read the official source — NCT03102918Medication studyAges 18–65United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- BelmontSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Study information
Study start dateStarted: February 20, 2016
- Recruitment status
- Completed
- Enrollment listed in the registry
- 10
- Sponsor
- Mclean Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT03102918
- Official title
Show the full official title
Cannabidiol Pharmacotherapy for Adults With Cannabis Use Disorder
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Belmont
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Mclean Hospital, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including Cannabidiol and Placebo.
Who was this study for?
Listed age limits: 18 years to 65 years.
